Are adaptive randomised trials or non-randomised studies the best way to address the Ebola outbreak in west Africa?
Simone Lanini, Alimuddin I. Zumla, John P. A. Ioannidis et al. · The Lancet Infectious Diseases · 2015
Cited by 44 works. doi:10.1016/s1473-3099(15)70106-4 Open-access PDF
Authors
- Simone Lanini
- Alimuddin I. Zumla
- John P. A. Ioannidis
- Antonino Di
- Sanjeev Krishna
- Lawrence O. Gostin
- Enrico Girardi
- Michel Pletschette
- Gino Strada
- Aldo Baritussio
- Gina Portella
- Giovanni Apolone
- Silvio Cavuto
- Roberto Satolli
- Peter G. Kremsner
- Francesco Vairo
- Giuseppe Ippolito
References
- Ebola Virus Disease in West Africa — The First 9 Months of the Epidemic and Forward Projections
- Randomized Clinical Trials
- What Makes Clinical Research Ethical?
- Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp
- ETHICS IN COOPERATIVE CLINICAL TRIALS
- Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model
- Treatment of Ebola Hemorrhagic Fever with Blood Transfusions from Convalescent Patients
- The randomized controlled clinical trial
- Ebola haemorrhagic fever outbreak in Masindi District, Uganda: outbreak description and lessons learned
- A Case of Severe Ebola Virus Infection Complicated by Gram-Negative Septicemia